Bladder Cancer Diagnosis and Identification of Clinically Significant Disease by Combined Urinary Detection of Mcm5 and Nuclear Matrix Protein 22

Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer

(2014) G Mowatt et al.   HEALTH TECHNOLOGY ASSESSMENT

Expression of microRNAs in the Urine of Patients With Bladder Cancer

(2012) Gang Wang et al.   Clinical Genitourinary Cancer

Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?

(2010) Georgios Gakis et al.   CURRENT OPINION IN UROLOGY

Eukaryotic DNA replication control: Lock and load, then fire

(2009) Dirk Remus et al.   CURRENT OPINION IN CELL BIOLOGY

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

(2009) Merle Hanke et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection

(2008) Yair Lotan et al.   BJU INTERNATIONAL

Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates

(2008) L Ayaru et al.   BRITISH JOURNAL OF CANCER